HomeFBLG • NASDAQ
Fibrobiologics Inc
add
$0.61
0.29%
After Hours:(4.56%)+0.028
$0.64
Closed: Jul 3, 5:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.53M | 31.33% |
Net income | -4.97M | 41.30% |
Net profit margin | — | — |
Earnings per share | -0.14 | — |
EBITDA | -4.48M | -31.13% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.67M | 6.24% |
Total assets | 11.43M | 0.24% |
Total liabilities | 9.08M | -40.53% |
Total equity | 2.35M | — |
Shares outstanding | 38.26M | — |
Price to book | 10.17 | — |
Return on assets | -81.29% | — |
Return on capital | -99.56% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.97M | 41.30% |
Cash from operations | -5.28M | -23.39% |
Cash from investing | -43.00K | -437.50% |
Cash from financing | — | — |
Net change in cash | -5.32M | -429.15% |
Free cash flow | -3.78M | -278.47% |
Previous close
$0.61
Day range
$0.60 - $0.65
Year range
$0.59 - $5.60
Market cap
23.42M USD
Avg Volume
420.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2021
Headquarters
Website
Employees
13
